Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study.
Doaa A MekkawySherif HamdyMaged Abdel NaseerHatem S ShehataAhmed Al HalfawyNevin M ShalabyGhaydaa A ShehataAnwar M AliAlaa ElmaznySandra M AhmedJumana H IsmailAml IbraheimHoda M Abdel-HamidRehab MagdyYounan Kabara AyoubAhmed E TahaNahla MerghanyNourhan M SolimanHaidy ElshebawySamar E S AbdelalLobna El-GhoneimyAussan Al-AthwariNirmeen A KishkMona A F NadaMarwa FarghalyAmr HassanMohamed I HegazyAhmed AbdelalimHusam S MouradAmira HassounaAlshimaa S OthmanTissa WijeratnePublished in: Brain sciences (2022)
Neurological involvement is common (48.63%) in COVID-19 patients within the first two weeks of the illness. This includes neurological symptoms such as anosmia, headaches, as well as a constellation of neurological syndromes such as stroke, encephalitis, transverse myelitis, and Guillain-Barré syndrome. Severity of acute COVID-19 illness and older age are the main risk factors.